NCT06921629

Brief Summary

The aim of this study is to investigate the prevalence of menstrual complaints and their impact on daily life activities (school/work absence, absence from social activities, sports) in adults and adolescents.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 11, 2023

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

March 26, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 10, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 11, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 11, 2026

Completed
Last Updated

April 10, 2025

Status Verified

April 1, 2025

Enrollment Period

3 years

First QC Date

March 26, 2025

Last Update Submit

April 3, 2025

Conditions

Keywords

DysmenorrheaHeavy Menstrual BleedingMenstrual complaintsImpact of menstrual complaintsdaily activitiesAdolescentsAdults

Outcome Measures

Primary Outcomes (2)

  • Impact of menstrual complaints (registred in the MEK-app)

    The impact of menstrual complaints (bleeding and pain) on daily activities in adolescents and adults registered in the MEK-app. Impact on daily life was assessed in the MEK app with the question: "Has your menstruation affected your daily activities?" Participants could respond with "yes" or "no."

    1 month

  • Prevalence of menstrual complaints

    Prevalence of dysmenorrhea and heavy menstrual bleeding

    1 month

Secondary Outcomes (2)

  • Risk of clotting disorder (self-BAT questionnaire)

    1 month

  • Knowledge about menstruation and management, measured with the Menstrual Health Literacy survey.

    1 month

Study Arms (2)

Adolescents

postmenarchal adolescents between 12 and 18 years old, (according to the WHO's definition of adolescents) with monthly menstruation

Other: Menstruatie Educatie Kalender (Menstrution Education Calendar) application (MEK-app)Other: Questionnaires

Adults

Postmenarchal adults between 19 and 60 years with monthly menstruation

Other: Menstruatie Educatie Kalender (Menstrution Education Calendar) application (MEK-app)Other: Questionnaires

Interventions

The MEK-APP is a mHealth application to evaluate menstrual complaints like heavy menstrual blood loss and dysmenorrhea. The MEK-APP is a calendar and facilitates daily monitoring of pain intensity using a Visual Analogue Scale (VAS), the amount of blood loss through a pictorial blood loss assessment chart (PBAC), and the impact of these complaints on daily life. The MEK-APP followed the waterfall methodology for software development and the usability was evaluated by both adults and adolescents(4). Furthermore, the MEK app has been approved by the privacy and security officers of Amsterdam UMC

AdolescentsAdults

After registration for this study via www.mijnmenstruatie.nl (which has also been approved by the privacy and security officers of Amsterdam UMC), participants received the first digital questionnaire. This questionnaire consisted of a baseline questionnaire, the electronic self bleeding assessment tool (e-self-BATH) and the Menstrual Health Literacy questionnaire. After using the MEK-app for at least one month, participants received an e-mail with the second questionnaire. This questionnaire consisted of the Menstrual Bleeding Questionnaire; Period ImPact and Pain Assesment; Pelvic Pain Impact Questionnaire; ENDOPAIN-4D; Endometriosis Health Profile 5 and iMTA Productivity Cost Questionnaire.

AdolescentsAdults

Eligibility Criteria

Age12 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Participants were recruited from social media channels Facebook (@Uterine Repair Center), Instagram (@MenstruatieApp) and Tiktok (@MenstruatieEducatieApp), schools during biology class and from outpatient clinics, including pediatrics and adolescent medicine and gynecology, regardless of their reason for coming.

You may qualify if:

  • post-menarcheal adolescents and adults aged 12-60 years,
  • having a menstrual cycle with monthly bleeding (also with an intra-uterine device or use of contraceptive pills),
  • speaking Dutch (MEK-app is available in Dutch only);
  • having a smartphone with the operating system Android or iOS and
  • obtaining informed consent from the participant and the parents of the participants aged 12-16 years.

You may not qualify if:

  • amenorrhea
  • incompleted questionnaires
  • not using the MEK-app for at least one period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amsterdam UMC

Amsterdam, North Holland, 1105AZ, Netherlands

Location

Related Publications (1)

  • Ozcan H, Burger NB, Derksen ME, Peute LW, Huirne JAF, De Leeuw RA. The differences between adults and adolescents using a mobile health application for menstrual complaints: A usability and qualitative study. Int J Med Inform. 2024 May;185:105382. doi: 10.1016/j.ijmedinf.2024.105382. Epub 2024 Feb 23.

    PMID: 38437753BACKGROUND

MeSH Terms

Conditions

DysmenorrheaMenorrhagia

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and SymptomsUterine HemorrhageUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhage

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Robert de Leeuw, MD, PhD

    Amsterdam UMC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD. Principal Investigator

Study Record Dates

First Submitted

March 26, 2025

First Posted

April 10, 2025

Study Start

May 11, 2023

Primary Completion

May 11, 2026

Study Completion

May 11, 2026

Last Updated

April 10, 2025

Record last verified: 2025-04

Locations